Literature DB >> 17980637

Development of a scoring system for assessment of outcome of early undifferentiated inflammatory synovitis.

Yasser El Miedany1, Sally Youssef, Annie N Mehanna, Maha El Gaafary.   

Abstract

BACKGROUND: The current paradigm for early undifferentiated arthritis suggests that persistent synovitis leads to erosive joint damage, which results in functional disability. Discriminating between different forms of early arthritis outcome is relevant for therapeutic decision-making and prevents the occurrence of circularity in diagnostic studies. Implementation of a prognostic model into clinical practice is highly required.
OBJECTIVE: To identify the prognostic factors at entry for the persistence of early inflammatory arthritis and to develop a scoring system to assess the outcome in patients presenting with early inflammatory arthritis.
METHODS: A cohort of 173 patients with early inflammatory arthritis, were assessed in a special early arthritis clinic. Case definition of synovitis was assessed clinically by the number of tender joint and swollen joint counts as well as symmetry of the affected joints and data were recorded. Baseline HAQ score, serum rheumatoid factor and anti-CCP titre were monitored. Patients satisfying the American College of Rheumatology classification criteria for RA and the European Spondyloarthropathy Study Group criteria for spondylo-arthropathry were excluded, as well as those with a specific rheumatic diagnosis. All the patients were reviewed every 3 months for 24 months period. Ultrasonography for both MCP and PIP joints, both hands, were performed at day of entry and 6 months after initial assessment. All patients had MRI both hands and wrist joints. The arthritis outcome recorded at 1-year follow up represented the gold standard for the diagnosis. Logistic regression analysis was performed to identify the independent factors (predictors) of persistent arthritis and accordingly a scoring system was invented that involved the predictors revealed from the analysis. A ROC curve was set to display the performance of the scoring system and a cut off point was selected taking into consideration a higher sensitivity than specificity, as this model will be mainly used as a screening tool.
RESULTS: During the follow up period, 93 patients showed evidence of self-limiting arthritis while 80 showed persistent arthritis. Duration of morning stiffness in minutes, percentage change in HAQ score after 3 months duration and anti-CCP positivity were the predictors of persistent arthritis. ROC curve analysis identified a cut off point of 121 above which the early arthritis patient would be more at risk of developing persistent arthritis.
CONCLUSION: Application of a model (scoring system) to stratify patients presenting with early persistent inflammatory arthritis from those with self-limiting disease can be attained. The developed model was found to be valid on the studied cohort. This model is important for standard clinical practice as the value of prediction of persistent arthritis has its great impact not only for identifying the patients but also on the therapeutic outcome as well.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17980637     DOI: 10.1016/j.jbspin.2007.04.021

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  16 in total

1.  Rheumatoid Arthritis: Early diagnosis and treatment outcomes.

Authors:  Behzad Heidari
Journal:  Caspian J Intern Med       Date:  2011

Review 2.  Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.

Authors:  Rohit Aggarwal; Katherine Liao; Raj Nair; Sarah Ringold; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-11-15

Review 3.  The epidemiology of early inflammatory arthritis.

Authors:  Johanna M W Hazes; Jolanda J Luime
Journal:  Nat Rev Rheumatol       Date:  2011-06-14       Impact factor: 20.543

4.  Optimizing therapy in inflammatory arthritis: prediction of relapse after tapering or stopping treatment for rheumatoid arthritis patients achieving clinical and radiological remission.

Authors:  Y El Miedany; M El Gaafary; S Youssef; I Ahmed; Sami Bahlas; M Hegazi; A Nasr
Journal:  Clin Rheumatol       Date:  2016-09-22       Impact factor: 2.980

Review 5.  PROMs in inflammatory arthritis: moving from static to dynamic.

Authors:  Yasser El Miedany
Journal:  Clin Rheumatol       Date:  2013-04-10       Impact factor: 2.980

6.  Turkish League Against Rheumatism (TLAR) Recommendations for the Pharmacological Management of Rheumatoid Arthritis: 2018 Update Under Guidance of Current Recommendations.

Authors:  Şebnem Ataman; İsmihan Sunar; Gürkan Yilmaz; Hatice Bodur; Kemal Nas; Fikriye Figen Ayhan; Özgür Akgül; Ayşen Akinci; Zuhal Altay; Murat Birtane; Derya Soy Buğdayci; Erhan Çapkin; Remzi Çevik; Yeşim Garip Çimen; M Tuncay Duruöz; Atilla Halil Elhan; Gülcan Gürer; Cahit Kaçar; Ayhan Kamanli; Ece Kaptanoğlu; Taciser Kaya; Hilal Kocabaş; Ömer Kuru; Meltem Alkan Melikoğlu; Sumru Özel; Aylin Rezvani; İlhan Sezer; Fatma Gül Yurdakul
Journal:  Arch Rheumatol       Date:  2018-07-09       Impact factor: 1.472

7.  The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis.

Authors:  Maria D Mjaavatten; Désirée van der Heijde; Till Uhlig; Anne J Haugen; Halvor Nygaard; Göran Sidenvall; Knut Helgetveit; Tore K Kvien
Journal:  Arthritis Res Ther       Date:  2010-05-05       Impact factor: 5.156

8.  Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Authors:  P Machado; I Castrejon; W Katchamart; R Koevoets; B Kuriya; M Schoels; L Silva-Fernández; K Thevissen; W Vercoutere; E Villeneuve; D Aletaha; L Carmona; R Landewé; D van der Heijde; J W J Bijlsma; V Bykerk; H Canhão; A I Catrina; P Durez; C J Edwards; M D Mjaavatten; B F Leeb; B Losada; E M Martín-Mola; P Martinez-Osuna; C Montecucco; U Müller-Ladner; M Østergaard; B Sheane; R M Xavier; J Zochling; C Bombardier
Journal:  Ann Rheum Dis       Date:  2010-08-19       Impact factor: 19.103

9.  Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: results from the NOR-VEAC cohort.

Authors:  Maria D Mjaavatten; Till Uhlig; Anne J Haugen; Halvor Nygaard; Göran Sidenvall; Knut Helgetveit; Tore K Kvien
Journal:  Arthritis Res Ther       Date:  2009-10-01       Impact factor: 5.156

10.  Marham-Mafasel decrease joint inflammation and IL-1β gene expression in rheumatoid arthritis animal model.

Authors:  Mohammad Majidi; Fatemeh Heidarnejad; Mohsen Naseri; Shahin Bonakdar; Maryam Salimi; Roya Yaraee
Journal:  Vet Med Sci       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.